Connecting sponsors with a global network of expertise and CDMO capabilities.
Booth #2925 | November 9–12, 2025 | San Antonio, Texas
AAPS PharmSci 360 is an annual event organized by the American Association of Pharmaceutical Scientists (AAPS). The event convenes thousands of pharmaceutical science professionals from around the world and across the drug development process to discuss the latest advancements in pharmaceutical science and technology.
Date: Monday, November 10, 2025
Time: 12:30 PM - 1:30 PM CT
Location: 360 Stage 4, Exhibit Hall
Presenters:
Nitin Kumar K. Swarnakar, Ph.D., NA Applications Lab Manager, BASF Corporation
Ramesh Muttavarapu, MS, Global SME for Solid Orals, Thermo Fisher Scientific
Unlock the next phase of innovation in pharmaceutical formulation. The co-presenters will highlight the science and practical considerations behind maximizing drug loading while ensuring consistent dissolution performance and manufacturing robustness. Case studies and process optimization examples will demonstrate how to anticipate challenges, avoid development pitfalls, and accelerate your path to successful ASD commercialization.
Date: November 9-12, 2025
Formant: In-person
Location: Henry B. Gonzalez Convention Center, San Antonio, Texas
Booth number: #2925
Event website: https://www.aaps.org/pharmsci/annual-meeting
Date: Monday, November 10, 2025
Time: 3:30 PM - 4:30 PM CT
Location: 360 Stage 4, Exhibit Hall
Presenters:
Anil Kane, PhD, Sr. Director, Global Technical Scientific Affairs, Thermo Fisher Scientific
Sanjay Konagurthu, PhD, Sr. Director, Science and Innovation, Thermo Fisher Scientific
The future of drug development is here. See how Thermo Fisher is transforming pharma with predictive modeling, AI-powered manufacturing, and real-time adaptive control. From cutting API waste to boosting efficiency and quality, this session reveals how digital tools are reshaping development timelines and unlocking breakthroughs.
Presented by our in-house experts, Anil Kane, PhD, sr. director, global technical scientific affairs; and Sanjay Konagurthu, PhD, sr. director, science and innovation.
Experience Thermo Fisher Scientific’s expertise through a collection of posters that highlight the digital models at the forefront of drug development, including our own OSDPredict.
Each poster distills the rigorous work of our scientists and demonstrates how our “science first” approach lays the foundation for digital innovation.
Developing oral solid dose and small molecule products involve countless critical decisions at every stage and “business as usual” is not a successful strategy. Where speed and efficiency are paramount, AI-driven tools and digital innovations embedded in the right place can help developers realize these objectives.
Visit us at Booth #2925 to explore our comprehensive CDMO capabilities specific to small molecule and OSD development and the modern technologies we utilize to enhance the efficiency, accuracy, and speed of the drug development processes.
Got questions? Want to discuss your project? Talk with one or our experts at Booth #2925
We look forward to meeting you in Texas.